These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2601215

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T, Taguchi H.
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [Abstract] [Full Text] [Related]

  • 45. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL, Nakada SY.
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [Abstract] [Full Text] [Related]

  • 46. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A.
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [Abstract] [Full Text] [Related]

  • 47. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M, Kawamura J, Ueda M, Okada Y, Takeuchi H, Yoshida O.
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [Abstract] [Full Text] [Related]

  • 48. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers.
    Ortiz-Alvarado O, Miyaoka R, Kriedberg C, Leavitt DA, Moeding A, Stessman M, Monga M.
    Urology; 2012 Feb; 79(2):282-6. PubMed ID: 22000931
    [Abstract] [Full Text] [Related]

  • 49. Heterozygous cystinuria and calcium oxalate urolithiasis.
    Carpentier PJ, Kurth KH, Blom W, Huijmans JG.
    J Urol; 1983 Aug; 130(2):302-4. PubMed ID: 6876277
    [Abstract] [Full Text] [Related]

  • 50. Calcium oxalate urinary calculi: clinical and chemical aspects.
    Elliot JS.
    Medicine (Baltimore); 1983 Jan; 62(1):36-43. PubMed ID: 6823212
    [Abstract] [Full Text] [Related]

  • 51. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO, Schmiedl A, Manoharan M.
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [Abstract] [Full Text] [Related]

  • 52. Effect of calcium treatment on urinary stone index after intestinal bypass for obesity.
    Holm CN, Hessov I.
    Digestion; 1981 Mar; 22(5):255-8. PubMed ID: 7308596
    [Abstract] [Full Text] [Related]

  • 53. Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.
    Allie-Hamdulay S, Rodgers AL.
    Urol Res; 2005 May; 33(2):116-24. PubMed ID: 15871014
    [Abstract] [Full Text] [Related]

  • 54. The composition of four-hour urine samples from patients with calcium oxalate stone disease.
    Berg C, Larsson L, Tiselius HG.
    Br J Urol; 1987 Oct; 60(4):301-6. PubMed ID: 3690199
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. The role of citrate complexes in preventing urolithiasis.
    Ashby RA, Sleet RJ.
    Clin Chim Acta; 1992 Sep 30; 210(3):157-65. PubMed ID: 1468138
    [Abstract] [Full Text] [Related]

  • 60. Chemical factors important to calcium nephrolithiasis: evidence for impaired hydroxycarboxylic acid absorption causing hyperoxaluria.
    Cowley DM, McWhinney BC, Brown JM, Chalmers AH.
    Clin Chem; 1987 Feb 30; 33(2 Pt 1):243-7. PubMed ID: 3802507
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.